Email Updates
Study
Emerging Classic
Patient perspectives on the use of artificial intelligence for skin cancer screening: a qualitative study.
Nelson CA, Pérez-Chada LM, Creadore A, et al. Patient perspectives on the use of artificial intelligence for skin cancer screening: a qualitative study. JAMA Dermatol. 2020;156(5):501-512. doi:10.1001/jamadermatol.2019.5014.
Copy Citation
Download Citation
April 1, 2020
Nelson CA, Pérez-Chada LM, Creadore A, et al. JAMA Dermatol. 2020;156(5):501-512.
Researchers in this study used semi-structured interviews to explore how patients perceive the use of direct-to-patient and clinician decision-support artificial intelligence (AI) tools for skin cancer screening. Common perceived benefits included increased diagnostic speed and health care access, while increased anxiety was a common risk. Patients perceived more accurate diagnoses (69%) and less accurate diagnoses (85%) to be both the greatest strength and weakness of these tools. The vast majority of patients (94%) expressed the importance of a symbiotic relationship between patients, physicians and AI tools. The related commentary discusses the importance of including the patient perspective in the development and implementation of AI tools in healthcare.
